Cite

MLA Citation

    S. Brown et al.. “Does travel time for SABR treatment, impact upon the management of early-stage inoperable NSCLC?.” Lung cancer, vol. 139, n.d., pp. S33–S34. http://access.bl.uk/ark:/81055/vdc_100099358130.0x000042
  
Back to record